RBC Capital Maintains Outperform on Facebook, Lowers Price Target to $415

RBC Capital analyst Brad Erickson maintains Facebook (NASDAQ:FB) with a Outperform and lowers the price target from $425 to $415.

byBenzinga Newsdesk

October 26, 2021

1 minute read

RBC Capital analyst Brad Erickson maintains Facebook (NASDAQ:FB) with a Outperform and lowers the price target from $425 to $415.

KBR Selected As Primary Provider Of Space Medicine Support To European Space Agency

By Bill Haddad

Today, 5:05 AM

KBR (NYSE:KBR) was selected to continue providing high-end astronaut medical support services for the European Space Agency's (ESA's) European Astronaut Centre (EAC) Space Medicine Office in Cologne,

KBR

South Korea May Block Alphabet’s Google and Apple from Charging Software Developers Commissions on in-app Purchases

By Charles Gross

Today, 5:05 AM

-Reuters https://www.reuters.com/technology/skorea-set-curb-google-apple-commission-dominance-2021-08-24/

AAPL

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout

By Shanthi Rexaline

Today, 5:05 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4)

ADTX

Flushing Financial Q3 Adj. EPS $0.62 Beats $0.60 Estimate

By Michael Horton

Today, 5:05 AM

Flushing Financial (NASDAQ:FFIC) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0.60 by 3.33 percent. This is a 29.55 percent decrease over earnings of $0.88 per share from

FFIC

RBC Capital Maintains Outperform on Facebook, Lowers Price Target to $415

Related Posts

KBR Selected As Primary Provider Of Space Medicine Support To European Space Agency

South Korea May Block Alphabet’s Google and Apple from Charging Software Developers Commissions on in-app Purchases

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout

Flushing Financial Q3 Adj. EPS $0.62 Beats $0.60 Estimate